Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
Erasmus Medical Center, Rotterdam, Netherlands.
Ann Clin Transl Neurol. 2021 Jan;8(1):95-110. doi: 10.1002/acn3.51249. Epub 2020 Nov 28.
MAPT mutations typically cause behavioral variant frontotemporal dementia with or without parkinsonism. Previous studies have shown that symptomatic MAPT mutation carriers have frontotemporal atrophy, yet studies have shown mixed results as to whether presymptomatic carriers have low gray matter volumes. To elucidate whether presymptomatic carriers have lower structural brain volumes within regions atrophied during the symptomatic phase, we studied a large cohort of MAPT mutation carriers using a voxelwise approach.
We studied 22 symptomatic carriers (age 54.7 ± 9.1, 13 female) and 43 presymptomatic carriers (age 39.2 ± 10.4, 21 female). Symptomatic carriers' clinical syndromes included: behavioral variant frontotemporal dementia (18), an amnestic dementia syndrome (2), Parkinson's disease (1), and mild cognitive impairment (1). We performed voxel-based morphometry on T1 images and assessed brain volumetrics by clinical subgroup, age, and mutation subtype.
Symptomatic carriers showed gray matter atrophy in bilateral frontotemporal cortex, insula, and striatum, and white matter atrophy in bilateral corpus callosum and uncinate fasciculus. Approximately 20% of presymptomatic carriers had low gray matter volumes in bilateral hippocampus, amygdala, and lateral temporal cortex. Within these regions, low gray matter volumes emerged in a subset of presymptomatic carriers as early as their thirties. Low white matter volumes arose infrequently among presymptomatic carriers.
A subset of presymptomatic MAPT mutation carriers showed low volumes in mesial temporal lobe, the region ubiquitously atrophied in all symptomatic carriers. With each decade of age, an increasing percentage of presymptomatic carriers showed low mesial temporal volume, suggestive of early neurodegeneration.
MAPT 突变通常导致伴有或不伴有帕金森病的行为变异额颞叶痴呆。先前的研究表明,有症状的 MAPT 突变携带者存在额颞叶萎缩,但关于是否有症状前携带者存在灰质体积降低的研究结果存在差异。为了阐明是否有症状前携带者在症状期发生萎缩的区域存在较低的结构性脑体积,我们使用体素方法研究了一大群 MAPT 突变携带者。
我们研究了 22 名有症状的携带者(年龄 54.7±9.1,13 名女性)和 43 名有症状前的携带者(年龄 39.2±10.4,21 名女性)。有症状携带者的临床综合征包括:行为变异额颞叶痴呆(18 名)、遗忘性痴呆综合征(2 名)、帕金森病(1 名)和轻度认知障碍(1 名)。我们对 T1 图像进行了基于体素的形态测量,并按临床亚组、年龄和突变亚型评估了脑体积。
有症状的携带者表现出双侧额颞叶皮层、脑岛和纹状体的灰质萎缩,以及双侧胼胝体和钩束的白质萎缩。大约 20%的无症状携带者在双侧海马体、杏仁核和外侧颞叶皮层有低灰质体积。在这些区域,一些无症状携带者早在三十多岁时就出现了低灰质体积。无症状携带者中低白质体积很少出现。
一部分无症状的 MAPT 突变携带者在所有有症状携带者普遍萎缩的内侧颞叶区域表现出体积较低。随着每个十年的年龄增长,越来越多的无症状携带者出现内侧颞叶体积低,提示早期神经退行性变。